SCHEMBL8169678

SCHEMBL8169678

O=C1CSCc2cc(Br)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP1 P53582 2/20 0.44
▸ PARP10 Q53GL7 2/20 0.43
▸ TDP2 O95551 1/20 0.43
▸ PARP11 Q9NR21 1/20 0.43
▸ S100A4 P26447 1/20 0.42
▸ SRD5A1 P18405 2/20 0.39
▸ SRD5A2 P31213 1/20 0.39
▸ PTPRC P08575 1/20 0.37
▸ BCL2 P10415 2/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA4 P22748 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ CMA1 P23946 1/20 0.34
▸ AHR P35869 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6484286 0.86 SRD5A1 (0.44) METAP1PARP10TDP2PARP11S100A4
SCHEMBL1985601 0.85 PARP10 (0.43) METAP1PARP10TDP2PARP11S100A4
SCHEMBL30759524 0.85 PARP10 (0.43) METAP1PARP10TDP2PARP11S100A4
SCHEMBL8474486 0.77 METAP1 (0.44) METAP1PARP10PARP11SRD5A1CA1
SCHEMBL2818053 0.77 TDP2 (0.43) TDP2MAOAMAOB
SCHEMBL5106774 0.77 METAP1 (0.44) METAP1PARP10S100A4SRD5A1SRD5A2
SCHEMBL5113686 0.77 SRD5A1 (0.38) PARP10TDP2SRD5A1CA1CA2
SCHEMBL14488028 0.75 METAP1 (0.60) METAP1PARP10TDP2PARP11S100A4
SCHEMBL1197666 0.74 PNMT (0.42) METAP1PARP10TDP2PARP11TDP1
SCHEMBL27039 0.74 CASP1 (0.59) METAP1PARP10TDP2PARP11S100A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6110910-A ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS, ANTIRHEUMATIC AGENTS, ANTICARCINOGENIC AGENTS DUPONT PHARMACEUTICALS (US) 2000-08-29 — — US disclosed
US-5874441-A TREATMENT OF AUTOIMMUNE DISEASES, INFLAMMATION DUPONT PHARMACEUTICALS COMPANY (US) 1999-02-23 — — US disclosed
US-5639759-A ORGAN TRANSPLANTATION; AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS; SKIN DISORDERS; ANTIARTHRITIC AGENTS; ANTICANCER AGENTS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-06-17 — — US disclosed
EP-0716652-A1 CARBOCYCLIC AND HETEROCYCLIC FUSED-RING QUINOLINECARBOXYLIC ACIDS USEFUL AS IMMUNOSUPPRESSIVE AGENTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-06-19 — — EP disclosed
US-5428040-A Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-06-27 — — US disclosed
WO-1995006640-A1 CARBOCYCLIC AND HETEROCYCLIC FUSED-RING QUINOLINECARBOXYLIC ACIDS USEFUL AS IMMUNOSUPPRESSIVE AGENTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-03-09 — — WO disclosed
Send feedback